BrazilTaevas Global acts as your authorized legal representative before ANVISA, enabling food and dietary supplement manufacturers to register products, maintain compliance, and operate confidently in Brazil's high-growth market. From initial filings to ongoing
Our legal representation service is built on six interconnected pillars that cover every dimension of regulatory compliance, market entry, and sustained commercial presence in Brazil.
We serve as your designated legal representative before ANVISA, fulfilling the mandatory requirement for foreign manufacturers to have a locally registered entity accountable for product compliance. Our team manages all correspondence, notifications, and regulatory interactions on your behalf, ensuring no filing deadline or query goes unanswered.
Our four-stage engagement model takes you from initial product assessment through full ANVISA legal representation activation, with clear milestones and dedicated regulatory counsel at every step.
We begin with a structured intake session to collect your product portfolio details, existing documentation, target categories, and commercial timeline. Our regulatory team reviews each product against ANVISA's current classification framework to determine whether registration, notification, or exemption applies.
You receive a written preliminary assessment within three business days covering product classification, estimated timelines, documentation gaps, and a fee schedule. This assessment forms the foundation of your regulatory strategy and prevents misclassification errors that commonly delay market entry by six months or more.
Brazil is the largest food and dietary supplement market in Latin America, driven by a population of over 215 million and rising health consciousness post-pandemic. Urban middle-class consumers are the primary growth engine, with protein supplements, vitamins, and functional foods recording the strongest category gains. International brands that localize effectively consistently outperform generic domestic competitors.
ANVISA's framework for food and dietary supplements is one of the most detailed in the Americas, requiring product-specific registration or notification, Portuguese-language labeling, and a locally registered legal representative for all foreign manufacturers. Non-compliance results in port-of-entry detentions, product recalls, and fines that can exceed R$1.5 million per infraction. Engaging experienced legal representation before market entry is not optional — it is a statutory requirement.
The Brazilian sports nutrition and functional food segment has grown at double-digit rates annually, with whey protein, omega-3, and probiotic products among the top-selling categories. E-commerce now accounts for a significant share of supplement sales, creating new distribution channels that require careful regulatory attention to online claims and direct-to-consumer labeling standards. Brands that achieve ANVISA registration gain a significant trust signal with Brazilian retailers and consumers.
Brazil's mandatory front-of-pack warning label system, introduced under IN 75/2020, requires high-sugar, high-sodium, and high-saturated-fat products to carry black octagonal warning symbols — one of the strictest such systems globally. Companies entering the market must reformulate or clearly disclose nutritional thresholds to avoid mandatory warnings that reduce shelf appeal. Taevas Global monitors ANVISA's ongoing updates to these thresholds to keep client products ahead of compliance deadlines.
Every Taevas Global Legal Representation engagement for Food & Dietary Supplements in Brazil includes these eight core deliverables, structured to take you from regulatory assessment to active market presence.
A written analysis of each product's ANVISA classification, applicable resolutions, and the registration or notification pathway required for lawful sale in Brazil.
Complete preparation of all ANVISA-required documentation including formulation summaries, safety data, manufacturer GMP certificates, and product specifications in Portuguese.
Cross-referencing of all active and inactive ingredients against ANVISA's positive lists and restricted substance schedules to identify non-compliant components before submission.
Execution and registration of all legal documents appointing Taevas Global as your authorized representative before ANVISA, including the mandatory Responsabilidade Tecnica declaration.
Detailed audit of your product labels against RDC 429/2020, IN 75/2020, and RDC 243/2018, with a corrected artwork brief ready for your design team to implement.
Electronic submission of all dossiers via SOLICITA, daily queue monitoring, and timely responses to ANVISA deficiency notices to prevent application rejection.
Ongoing surveillance of ANVISA regulatory updates, renewal deadline tracking, and proactive alerts for any changes that affect your registered products or labeling requirements.
A named regulatory specialist available for direct consultation on product extensions, formula modifications, promotional claims review, and ANVISA inspection preparation throughout your engagement.
Your products are successful in Europe, North America, or Asia, and Brazil's growing middle class represents a compelling next market. However, ANVISA's requirement for a locally registered legal representative means you cannot sell a single unit without first establishing compliant representation. You need a partner who knows the system, speaks the regulatory language, and can get your products to market without costly missteps.
Speak with a Taevas Global regulatory specialist today to receive a no-obligation preliminary assessment of your food or dietary supplement products for the Brazil market. We will identify your ANVISA pathway, estimate your timeline, and outline exactly what legal representation with Taevas Global includes.